Schmitt Industries (SMIT) Competitors $0.02 0.00 (0.00%) As of 10/17/2025 Add Compare Share Share Competitors Stock AnalysisChartCompetitorsSEC FilingsShort InterestTrendsBuy This Stock SMIT vs. TBIO, SPEC, THMO, HTGMQ, OLITW, PRENW, QSIAW, SMAPW, TT, and KEYSShould you be buying Schmitt Industries stock or one of its competitors? The main competitors of Schmitt Industries include Telesis Bio (TBIO), Spectaire (SPEC), ThermoGenesis (THMO), HTG Molecular Diagnostics (HTGMQ), OmniLit Acquisition (OLITW), Prenetics Global (PRENW), Quantum-Si (QSIAW), SportsMap Tech Acquisition (SMAPW), Trane Technologies (TT), and Keysight Technologies (KEYS). These companies are all part of the "measuring and control equipment" industry. Schmitt Industries vs. Its Competitors Telesis Bio Spectaire ThermoGenesis HTG Molecular Diagnostics OmniLit Acquisition Prenetics Global Quantum-Si SportsMap Tech Acquisition Trane Technologies Keysight Technologies Telesis Bio (NASDAQ:TBIO) and Schmitt Industries (NASDAQ:SMIT) are both small-cap measuring and control equipment companies, but which is the superior business? We will compare the two businesses based on the strength of their profitability, analyst recommendations, media sentiment, dividends, risk, earnings, valuation and institutional ownership. Do insiders and institutionals believe in TBIO or SMIT? 37.6% of Telesis Bio shares are owned by institutional investors. 24.5% of Telesis Bio shares are owned by insiders. Comparatively, 17.1% of Schmitt Industries shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term. Which has more volatility & risk, TBIO or SMIT? Telesis Bio has a beta of 2.72, meaning that its share price is 172% more volatile than the S&P 500. Comparatively, Schmitt Industries has a beta of -0.42, meaning that its share price is 142% less volatile than the S&P 500. Is TBIO or SMIT more profitable? Schmitt Industries has a net margin of 0.00% compared to Telesis Bio's net margin of -336.59%. Company Net Margins Return on Equity Return on Assets Telesis Bio-336.59% N/A -61.89% Schmitt Industries N/A N/A N/A Does the media favor TBIO or SMIT? In the previous week, Telesis Bio's average media sentiment score of 0.00 equaled Schmitt Industries'average media sentiment score. Company Overall Sentiment Telesis Bio Neutral Schmitt Industries Neutral Which has higher earnings and valuation, TBIO or SMIT? Schmitt Industries has lower revenue, but higher earnings than Telesis Bio. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioTelesis Bio$225.09M0.00-$47.72M-$28.200.00Schmitt Industries$9.89M0.01-$3.28MN/AN/A SummaryTelesis Bio and Schmitt Industries tied by winning 4 of the 8 factors compared between the two stocks. Get Schmitt Industries News Delivered to You Automatically Sign up to receive the latest news and ratings for SMIT and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding SMIT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip Chart SMIT vs. The Competition Export to ExcelMetricSchmitt IndustriesProcess control instruments IndustryIndustrials SectorNASDAQ ExchangeMarket Cap$59K$166.22M$7.79B$10.55BDividend YieldN/AN/A4.59%4.81%P/E RatioN/AN/A284.1627.13Price / Sales0.016.531,246.85132.72Price / CashN/AN/A27.7460.81Price / BookN/A5.834.796.52Net Income-$3.28M-$31.84M$790.12M$276.93M7 Day PerformanceN/A-2.86%0.10%1.93%1 Month PerformanceN/A-11.30%1.19%2.19%1 Year PerformanceN/A13.81%26.51%34.62% Schmitt Industries Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)SMITSchmitt IndustriesN/A$0.02flatN/AN/A$59K$9.89M0.00160TBIOTelesis BioN/A$0.01-3.3%N/A-99.6%$21K$225.09M0.00200SPECSpectaireN/A$0.00flatN/A-97.3%$7KN/A0.008THMOThermoGenesisN/AN/AN/AN/A$1K$9.61M0.0040Gap UpHTGMQHTG Molecular DiagnosticsN/A$0.00flatN/AN/A$0.00$6.37M0.0090OLITWOmniLit AcquisitionN/A$0.09-0.3%N/A+275.3%$0.00N/A0.003Gap DownPRENWPrenetics GlobalN/A$0.03-12.5%N/A+145.5%$0.00$57.05M0.001Positive NewsShort Interest ↑Gap DownQSIAWQuantum-SiN/A$0.30-2.5%N/A+687.5%$0.00$3.41M0.00150News CoveragePositive NewsShort Interest ↓Gap UpSMAPWSportsMap Tech AcquisitionN/A$0.05+18.4%N/A+80.1%$0.00N/A0.00N/AGap UpHigh Trading VolumeTTTrane Technologies4.3971 of 5 stars$422.93-0.4%$457.73+8.2%+3.4%$94.52B$19.84B33.5445,000Positive NewsAnalyst ForecastKEYSKeysight Technologies4.6796 of 5 stars$170.19-1.8%$187.38+10.1%+1.5%$29.79B$4.98B54.2015,500Positive NewsAnalyst Upgrade Related Companies and Tools Related Companies Telesis Bio Competitors Spectaire Competitors ThermoGenesis Competitors HTG Molecular Diagnostics Competitors OmniLit Acquisition Competitors Prenetics Global Competitors Quantum-Si Competitors SportsMap Tech Acquisition Competitors Trane Technologies Competitors Keysight Technologies Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:SMIT) was last updated on 10/19/2025 by MarketBeat.com Staff From Our PartnersRobinhood warningA strange chasm is coming to Wall Street... It's already creating millionaires and billionaires at the fast...Stansberry Research | SponsoredOctober 16 Changes the Microchip Game — and InvestingWhile everyone's chasing the same AI plays, George Gilder is focused on something completely different. He ...Banyan Hill Publishing | Sponsored$100 Trillion “AI Metal” Found in American Ghost TownJeff Brown recently traveled to a ghost town in the middle of an American desert… To investigate what could...Brownstone Research | SponsoredMagnificent 7 being replaced by the “Hidden 7”?BULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on...Chaikin Analytics | Sponsored$3,600 gold is nice ... but here’s what most gold bugs are missingGold just surged past $3,600, but Weiss Ratings expert Sean Brodrick says the real upside is in select gold st...Weiss Ratings | SponsoredBitcoin grabs headlines, but smart money likes this tokenBitcoin grabs headlines, but smart money likes this token My research team has identified the token positio...Crypto 101 Media | SponsoredFront-Run Buffett's Shocking Gold MoveA Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Schmitt Industries, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Schmitt Industries With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free SMIT Stock Alerts